Literature DB >> 7164822

Comparison of the effects of a new vasodilator pinacidil and nifedipine on isolated blood vessels.

E Mikkelsen, O L Pedersen.   

Abstract

In isolated human crural veins studied in vitro pinacidil (0.038-380 microM) caused a concentration-related inhibition of noradrenaline, 18 microM (NA) and 127 mM K+-induced contractions. Pinacidil was more potent in inhibiting the NA-contraction than that induced by K+, whereas the reverse was seen for nifedipine. At the highest concentrations greater inhibitions of the NA-induced contractions could be obtained with pinacidil than with nifedipine. The inhibitory effect of pinacidil on the K+-induced contractions was eliminated during a 1 hr wash-out period. In contrast to this, the inhibitory effect of nifedipine could not be eliminated during 4 hrs repeated wash-out. Pinacidil was completely devoid of inhibitory effect on 45Ca net influx in rat aorta, whereas nifedipine caused a significant reduction of influx. The results indicate that both pinacidil and nifedipine are effective vasodilatators in human vessels. Pinacidil seems to be more effective in NA-induced contractions than does nifedipine. The mechanism of action of pinacidil cannot be attributed to an inhibitory effect on cellular calcium entry.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7164822     DOI: 10.1111/j.1600-0773.1982.tb01045.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  11 in total

Review 1.  Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H A Friedel; R N Brogden
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

Review 2.  Pinacidil. Preclinical investigations.

Authors:  I Ahnfelt-Rønne
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Smooth muscle K+ channel openers; their pharmacology and clinical potential.

Authors:  A H Weston
Journal:  Pflugers Arch       Date:  1989       Impact factor: 3.657

4.  Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.

Authors:  K Masuzawa; T Matsuda; M Asano
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

5.  The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques.

Authors:  J S Southerton; A H Weston; K M Bray; D T Newgreen; S G Taylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

6.  Acute haemodynamic effects of pinacidil in man.

Authors:  D P Nicholls; J G Murtagh; M E Scott; P Morton; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

7.  Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.

Authors:  J W Ward; A McBurney; P R Farrow; P Sharp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  In vitro studies on the mode of action of pinacidil.

Authors:  A H Weston; K M Bray; S Duty; A D McHarg; D T Newgreen; J S Southerton
Journal:  Drugs       Date:  1988       Impact factor: 9.546

9.  Vasodilatation with pinacidil. Mode of action in rat resistance vessels.

Authors:  L M Videbaek; C Aalkjaer; M J Mulvany
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  Renal effects of pinacidil in hypertensive patients on chronic beta-blocker therapy.

Authors:  L R Krusell; C K Christensen; O Lederballe Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.